Cardiovascular disease models: A game changing paradigm in drug discovery and screening

Author:

Savoji Houman,Mohammadi Mohammad Hossein,Rafatian Naimeh,Toroghi Masood Khaksar,Wang Erika Yan,Zhao Yimu,Korolj Anastasia,Ahadian Samad,Radisic Milica

Funder

CIHR

NSERC

NSERC Steacie Fellowship

Heart and Stroke Foundation Grant-in-Aid

NSERC-CIHR Collaborative Health Research Grant

M.R. and National Institutes of Health Grant

Fonds de Recherche du Québec - Nature et Technologies

Canadian Institutes of Health Research

Humane Society International

Humane Society of the United States

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference419 articles.

1. How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?;Laverty;Br. J. Pharmacol.,2011

2. Bringing Vioxx Back to Market;Ross,2018

3. The lessons of Vioxx—drug safety and sales;Waxman;N. Engl. J. Med.,2005

4. Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis;Onakpoya;Crit. Rev. Toxicol.,2016

5. Can Pharmacogenetics Help Rescue Drugs Withdrawn from the Market?;Shah,2006

Cited by 167 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3